ERBB2 and triple-negative breast carcinoma: Another cancer with a significant mortality rate is triple negative breast cancer (TNBC) that is negative for estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (Her-2).